Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Venoms and Toxins
  4. Volume 2, Issue 2
  5. Article
Volume 2, Issue 2
  • ISSN: 2666-1217
  • E-ISSN: 2666-1225

Abstract

Venoms from the deadliest animals, including spiders, scorpians, bees, and centipedes, are composed of a complex mixture of various peptides developed to catch prey and defend other animals. Venoms are composed of several bioactive molecules such as proteins and peptides that modify physiological conditions in other organisms. These bioactive peptides penetrate tissues and blood vessels to encounter numerous receptors and modulate ion channel their activities. Venoms are used to treat various medical issues, including cardiovascular diseases. Venom peptides regulate several ion channel behaviors, such as voltage-gated sodium (Na), calcium (Ca) and potassium (K) channels, and are set as a therapeutic approach. In this perspective, we emphasize the effect of isolated lethal venomous peptides on cardiac ionic channels and their mechanisms of action for the cure. We also summarize the highlights and molecular details of their toxin-receptor interactions and prospects to develop peptide therapeutics for respective cardiac electrophysiological diseases.

© 2022 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/vat/10.2174/2666121702666220425130212
2022-08-01
2025-03-01

  • From This Site

    /content/journals/vat/10.2174/2666121702666220425130212
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. WalkerA.A. RobinsonS.D. HamiltonB.F. UndheimE.A.B. KingG.F. Deadly proteomes: A practical guide to proteotranscriptomics of animal venoms.Proteomics20202017-18e190032410.1002/pmic.201900324 32820606
     [Google Scholar]
  2. LewisR.J. GarciaM.L. Therapeutic potential of venom peptides.Nat. Rev. Drug Discov.2003210790802Available from: www.nature.com/reviews/drugdisc 10.1038/nrd1197 14526382
     [Google Scholar]
  3. ZhaoF LanX LiT XiangY ZhaoF ZhangY Proteotranscriptomic analysis and discovery of the profile and diversity of toxin-like proteins in centipede.Mol Cell Proteomics. Elsevier Inc2018177092010.1074/mcp.RA117.000431
     [Google Scholar]
  4. ChuY. QiuP. YuR. Toxins centipede venom peptides acting on ion channels.Toxins (Basel)2020124118Available from: www.mdpi.com/journal/toxins 10.3390/toxins12040230
     [Google Scholar]
  5. KingG.F. Venoms as a platform for human drugs: translating toxins into therapeutics.Expert Opin. Biol. Ther.201111111469148410.1517/14712598.2011.621940 21939428
     [Google Scholar]
  6. OliveraB.M. EssayE.E.E.E. Just Lecture, 1996. Conus venom peptides, receptor and ion channel targets, and drug design: 50 million years of neuropharmacology.Mol. Biol. Cell19978112101210910.1091/mbc.8.11.2101 9362055
     [Google Scholar]
  7. DutertreS.Ã. LewisR.J. Use of Venom Peptides to Probe ion channels structure and function.J. Biol. Chem.2010285133151332010.1074/jbc.R109.076596
     [Google Scholar]
  8. BaronA. DiochotS. SalinasM. DevalE. NoëlJ. LinguegliaE. Venom toxins in the exploration of molecular, physiological and pathophysiological functions of acid-sensing ion channels.Toxicon Pergamon20137518720410.1016/j.toxicon.2013.04.008 23624383
     [Google Scholar]
  9. RongM. YangS. WenB. MoG. KangD. LiuJ. Peptidomics combined with cDNA library unravel the diversity of centipede venom.J. Proteomics20151142837
     [Google Scholar]
  10. González-MoralesL. Pedraza-EscalonaM. Diego-GarciaE. Restano-CassuliniR. BatistaC.V.F. GutiérrezM del C. Proteomic characterization of the venom and transcriptomic analysis of the venomous gland from the Mexican centipede Scolopendra viridis.J. Proteomics2014111224237
     [Google Scholar]
  11. TerlauH. OliveraB.M. Conus venoms: A rich source of novel ion channel-targeted peptides.Physiol. Rev.2004841416810.1152/physrev.00020.2003 14715910
     [Google Scholar]
  12. SonodaY. HadaN. KanedaT. A synthetic glycosphingolipid-induced antiproliferative effect in melanoma cells is associated with suppression of FAK, Akt, and Erk activation.Biol. Pharm. Bull.20083161279128310.1248/bpb.31.1279 18520069
     [Google Scholar]
  13. ChengJ. WenJ. WangN. WangC. XuQ. YangY. Ion Channels and vascular diseases.Arterioscler. Thromb. Vasc. Biol.2019395e146e15610.1161/ATVBAHA.119.312004 31017824
     [Google Scholar]
  14. CatterallW.A. Structure and function of voltage-gated ion channels.Annu. Rev. Biochem.19956449353110.1146/annurev.bi.64.070195.002425 7574491
     [Google Scholar]
  15. YuS. LiG. HuangC.L-H. LeiM. WuL. Late sodium current associated cardiac electrophysiological and mechanical dysfunction.Pflugers Arch.2018470346146910.1007/s00424‑017‑2079‑7 29127493
     [Google Scholar]
  16. Ufret-VincentyC.A. BaroD.J. LedererW.J. RockmanH.A. QuiñonesL.E. SantanaL.F. Role of sodium channel deglycosylation in the genesis of cardiac arrhythmias in heart failure.J. Biol. Chem.200127630281972820310.1074/jbc.M102548200 11369778
     [Google Scholar]
  17. RothG.A. JohnsonC.O. AbateK.H. Global Burden of Cardiovascular Diseases CollaborationThe burden of cardiovascular diseases among US States, 1990-2016.JAMA Cardiol.20183537538910.1001/jamacardio.2018.0385 29641820
     [Google Scholar]
  18. FerrazC.R. ArrahmanA. XieC. Multifunctional toxins in snake venoms and therapeutic implications: From pain to hemorrhage and necrosis.Front. Ecol. Evol.20197218Available from: https://www.frontiersin.org/article/10.3389/fevo.2019.00218 [Internet]10.3389/fevo.2019.00218
     [Google Scholar]
  19. PalS.K. GomesA. DasguptaS.C. GomesA. Snake venom as therapeutic agents: From toxin to drug development.Indian J. Exp. Biol.2002401213531358 12974396
     [Google Scholar]
  20. KonshinaA.G. KrylovN.A. EfremovR.G. Cardiotoxins: Functional role of local conformational changes.J. Chem. Inf. Model.2017572799281010.1021/acs.jcim.7b00395
     [Google Scholar]
  21. KiniR.M. KohC.Y. Snake venom three-finger toxins and their potential in drug development targeting cardiovascular diseases.Biochem. Pharmacol.202018111410510.1016/j.bcp.2020.114105 32579959
     [Google Scholar]
  22. SongW. ShouW. Cardiac sodium channel Nav1.5 mutations and cardiac arrhythmia.Pediatr. Cardiol.201233694394910.1007/s00246‑012‑0303‑y 22460359
     [Google Scholar]
  23. HanD. TanH. SunC. LiG. Dysfunctional Nav1.5 channels due to SCN5A mutations.Exp. Biol. Med. (Maywood)20182431085286310.1177/1535370218777972 29806494
     [Google Scholar]
  24. WuZ. YangY. XieL. Toxicity and distribution of tetrodotoxin-producing bacteria in puffer fish Fugu rubripes collected from the Bohai sea of China.Toxicon200546447147610.1016/j.toxicon.2005.06.002 16051296
     [Google Scholar]
  25. WuY. MaH. ZhangF. ZhangC. ZouX. CaoZ. Selective voltage-gated sodium channel peptide toxins from animal venom: Pharmacological probes and analgesic drug development.ACS Chem. Neurosci.2018918719710.1021/acschemneuro.7b00406
     [Google Scholar]
  26. LiavasA. LignaniG. SchorgeS. Conservation of alternative splicing in sodium channels reveals evolutionary focus on release from inactivation and structural insights into gating.J. Physiol.2017595165671568510.1113/JP274693 28621020
     [Google Scholar]
  27. GonçalvesT.C. BoukaibaR. MolgóJ. Direct evidence for high affinity blockade of NaV1.6 channel subtype by huwentoxin-IV spider peptide, using multiscale functional approaches.Neuropharmacology201813340441410.1016/j.neuropharm.2018.02.016 29474819
     [Google Scholar]
  28. PriestB.T. BlumenthalK.M. SmithJ.J. WarrenV.A. SmithM.M. ProTx-I and ProTx-II: Gating modifiers of voltage-gated sodium channels.Toxicon200749219420110.1016/j.toxicon.2006.09.014 17087985
     [Google Scholar]
  29. MiddletonR.E. WarrenV.A. KrausR.L. HwangJ.C. LiuC.J. DaiG. Two tarantula peptides inhibit activation of multiple sodium channels.Biochemistry200241147341474710.1021/bi026546a
     [Google Scholar]
  30. LiX. Animal toxins influence voltage-gated sodium channel.Physiol. Behav.2016
     [Google Scholar]
  31. BelcherS. ZerilloC. LevensonR. RitchieJ. HoweJ. PandeV.S. Cloning of a sodium channel alpha subunit from rabbit Schwann cells.PNAS2012921103411038Available from: https://www.pnas.org/content/109/44/18102
    [Google Scholar]
  32. JiangD. TongguL. Gamal El-DinT.M. Structural basis for voltage-sensor trapping of the cardiac sodium channel by a deathstalker scorpion toxin.Nat. Commun.202112112810.1038/s41467‑020‑20078‑3 33397917
     [Google Scholar]
  33. LopezL. MontnachJ. NicolasS. JaquillardL. BeroudR. De WaardM. High-throughput screening of animal venoms for identification of compounds active on the cardiac Nav1.5 channel. Arch Cardiovasc Dis Suppl.Elsevier Masson202012258259
     [Google Scholar]
  34. MedlerS. Anesthetic MS-222 eliminates nerve and muscle activity in frogs used for physiology teaching laboratories.Adv. Physiol. Educ.2019431697510.1152/advan.00114.2018 30694709
     [Google Scholar]
  35. HuangW-C. HsiehY-S. ChenI-H. WangC-H. ChangH-W. YangC-C. Combined use of MS-222 (Tricaine) and isoflurane extends anesthesia time and minimizes cardiac rhythm side effects in adult zebrafish.Zebrafish2010729730410.1089/zeb.2010.0653
     [Google Scholar]
  36. SansomM.S.P. ShrivastavaI.H. BrightJ.N. TateJ. CapenerC.E. BigginP.C. Potassium channels: Structures, models, simulations.Biochim. Biophys. Acta Biomembr.2002156529430710.1016/S0005‑2736(02)00576‑X
     [Google Scholar]
  37. YellenG. The voltage-gated potassium channels and their relatives.Nature20024196902354210.1038/nature00978 12214225
     [Google Scholar]
  38. KuangQ. PurhonenP. HebertH. Structure of potassium channels.Cell. Mol. Life Sci.201572193677369310.1007/s00018‑015‑1948‑5 26070303
     [Google Scholar]
  39. Yarov-YarovoyV. BakerD. CatterallW.A. Voltage sensor conformations in the open and closed states in ROSETTA structural models of K channels.Proceedings of the National Academy of Sciences20061031972927Available from: http://www.pnas.orgcgidoi10.1073pnas.0602350103
    [Google Scholar]
  40. GuéguinouM ChantÔmeA FromontG KCa and Ca2+ channels: The complex thought.Biochim. Biophys. Acta Mol. Cell Res.2014184323222333
     [Google Scholar]
  41. TamargoJ. CaballeroR. GómezR. ValenzuelaC. DelpónE. Pharmacology of cardiac potassium channels.Cardiovasc. Res.200462193310.1016/j.cardiores.2003.12.026 15023549
     [Google Scholar]
  42. SchmittN. GrunnetM. OlesenS-P. Cardiac potassium channel subtypes: New roles in repolarization and arrhythmia.Physiol. Rev.201410.1152/physrev.00022.2013
     [Google Scholar]
  43. GrantA.O. Basic science for the clinical electrophysiologist cardiac ion channels the cardiac action potential general properties of ion channels.Circ. Arrhythm. Electrophysiol.20092185194Available from: http://ahajournals.org
    [Google Scholar]
  44. KlintJ.K. SenffS. RupasingheD.B. Spider-venom peptides that target voltage-gated sodium channels: Pharmacological tools and potential therapeutic leads.Toxicon Pergamon201260447849110.1016/j.toxicon.2012.04.337 22543187
     [Google Scholar]
  45. CsotiA. AlvaradoD. Cardoso-ArenasS. Novel spider peptide that affects the voltage gated potassium channel kv1.5.Biophys. J.20211203246a247a10.1016/j.bpj.2020.11.1610
     [Google Scholar]
  46. VandenbergJ.I. PerryM.D. PerrinM.J. MannS.A. KeY. HillA.P. hERG K+ channels: Structure, function, and clinical significance.Physiol. Rev.2012921393147810.1152/physrev.00036.2011
     [Google Scholar]
  47. WankeE. Restano-CassuliniR. Toxins interacting with ether-à-go-go-related gene voltage-dependent potassium channels.Toxicon200749223924810.1016/j.toxicon.2006.09.025 17097705
     [Google Scholar]
  48. GunayB.C. YurtseverM. DurdagiS. Elucidation of interaction mechanism of hERG1 potassium channel with scorpion toxins BeKm-1 and BmTx3b.J. Mol. Graph. Model.202096107504
     [Google Scholar]
  49. AngeloK. KorolkovaY.V. GrunnetM. A radiolabeled peptide ligand of the hERG channel, [125I]-BeKm-1.Pflugers Arch.20034471556310.1007/s00424‑003‑1125‑9 12905030
     [Google Scholar]
  50. EvansM.H. Mechanism of saxitoxin and tetrodotoxin poisoning.Br. Med. Bull.196925326326710.1093/oxfordjournals.bmb.a070715 5812102
     [Google Scholar]
  51. WangJ. SalataJ.J. BennettP.B. Saxitoxin is a gating modifier of HERG K+ channels.J. Gen. Physiol.2003121658359810.1085/jgp.200308812 12771193
     [Google Scholar]
  52. WangY. LuoZ. LeiS. LiS. LiX. YuanC. Effects and mechanism of gating modifier spider toxins on the hERG channel.Toxicon Pergamon2021189566410.1016/j.toxicon.2020.11.008 33212100
     [Google Scholar]
  53. KanjhanR. CoulsonE.J. AdamsD.J. BellinghamM.C. Tertiapin-Q blocks recombinant and native large conductance K+ channels in a use-dependent manner.J. Pharmacol. Exp. Ther.200531431353136110.1124/jpet.105.085928 15947038
     [Google Scholar]
  54. IsomotoS. KondoC. KurachiY. Inwardly rectifying potassium channels: Their molecular heterogeneity and function.Jpn. J. Physiol.1997471113910.2170/jjphysiol.47.11 9159640
     [Google Scholar]
  55. BidaudI. ChongA.C.Y. CarcouetA. Inhibition of G protein-gated K+ channels by tertiapin-Q rescues sinus node dysfunction and atrioventricular conduction in mouse models of primary bradycardia.Sci. Rep.2020101983510.1038/s41598‑020‑66673‑8 32555258
     [Google Scholar]
  56. YuH. LinZ. MattmannM.E. ZouB. TerrenoireC. ZhangH. Dynamic subunit stoichiometry confers a progressive continuum of pharmacological sensitivity by KCNQ potassium channels.Proc. Natl. Acad. Sci.201311087328737Available from: https://www.pnas.org/content/110/21/8732 10.1073/pnas.1300684110
     [Google Scholar]
  57. LiuZ-C. ZhangR. ZhaoF. ChenZ-M. LiuH-W. WangY-J. Venomic and transcriptomic analysis of centipede scolopendra subspinipes dehaani.J. Proteome Res.2012116197621210.1021/pr300881d
     [Google Scholar]
  58. LuoL. LiB. WangS. WuF. WangX. LiangP. Centipedes subdue giant prey by blocking KCNQ channels.Proc. Natl. Acad. Sci. USA201811516461651Available from: http://www.ncbi.nlm.nih.gov/pubmed/29358396 10.1073/pnas.1714760115
     [Google Scholar]
  59. DashT.S. ShafeeT. HarveyP.J. A centipede toxin family defines an ancient class of csαβ defensins.Cell Press2019272315326.e710.1016/j.str.2018.10.022 30554841
     [Google Scholar]
  60. ChenM. LiJ. ZhangF. LiuZ. Isolation and characterization of SsmTx-I, a Specific Kv2.1 blocker from the venom of the centipede Scolopendra Subspinipes Mutilans L. Koch.Ltd201420315916410.1002/psc.2588 24464516
     [Google Scholar]
  61. Öztekin LongM. Bone20082317Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3624763/pdf/nihms412728.pdf
    [Google Scholar]
  62. CatterallW.A. Voltage-gated calcium channels.Cold Spring Harb. Perspect. Biol.201138a00394710.1101/cshperspect.a003947 21746798
     [Google Scholar]
  63. LaverD.R. Ca2+ stores regulate ryanodine receptor Ca2+ release channels via luminal and cytosolic Ca2+ sites.Biophys. J.200792103541355510.1529/biophysj.106.099028 17351009
     [Google Scholar]
  64. LeeS. Pharmacological inhibition of voltage-gated Ca2+ channels for chronic pain relief.Curr. Neuropharmacol.201311660662010.2174/1570159X11311060005 24396337
     [Google Scholar]
  65. DiochotS. RichardS. Baldy-MoulinierM. NargeotJ. ValmierJ. Dihydropyridines, phenylalkylamines and benzothiazepines block N-, P/Q- and R-type calcium currents.Pflugers Arch.19954311101910.1007/BF00374372 8584405
     [Google Scholar]
  66. HwangI-W. ShinM.K. LeeY-J. N-type Cav channel inhibition by spider venom peptide of Argiope bruennichi.Mol. Cell. Toxicol.2021171596710.1007/s13273‑020‑00109‑2
     [Google Scholar]
  67. CardosoF.C. CastroJ. GrundyL. A spider-venom peptide with multitarget activity on sodium and calcium channels alleviates chronic visceral pain in a model of irritable bowel syndrome.Pain20211622569581Available from: https://journals.lww.com/pain/Fulltext/2021/02000/A_spider_venom_peptide_with_multitarget_activity.22.aspx 10.1097/j.pain.0000000000002041 32826759
     [Google Scholar]
  68. CatterallW.A. Perez-ReyesE. SnutchT.P. StriessnigJ. International union of pharmacology. XLVIII. Nomenclature and structure-function relationships of voltage-gated calcium channels.Pharmacol. Rev.2005574411425Available from: http://pharmrev.aspetjournals.org 10.1124/pr.57.4.5 16382099
     [Google Scholar]
  69. Quintero-HernándezV. Jiménez-VargasJ.M. GurrolaG.B. ValdiviaH.H. PossaniL.D. Scorpion venom components that affect ion-channels function.Toxicon Pergamon20137632834210.1016/j.toxicon.2013.07.012 23891887
     [Google Scholar]
  70. VieiraL.B. KushmerickC. HildebrandM.E. GarciaE. SteaA. CordeiroM.N. Inhibition of high voltage-activated calcium channels by spider toxin PnTx3-6.J. Pharmacol. Exp. Ther.200531413701377Available from: http://jpet.aspetjournals.org/content/314/3/1370 abstract
    [Google Scholar]
  71. LeãoR.M. CruzJ.S. DinizC.R. CordeiroM.N. BeirãoP.S.L. Inhibition of neuronal high-voltage activated calcium channels by the ω-phoneutria nigriventer Tx3-3 peptide toxin.Neuropharmacology200039101756176710.1016/S0028‑3908(99)00267‑1 10884557
     [Google Scholar]
  72. BourinetE. StotzS.C. SpaetgensR.L. Interaction of SNX482 with domains III and IV inhibits activation gating of α(1E) (Ca(V)2.3) calcium channels.Biophys. J.2001811798810.1016/S0006‑3495(01)75681‑0 11423396
     [Google Scholar]
  73. TotteneA. VolsenS. PietrobonD. Subunits form the pore of three cerebellar R-type calcium channels with different pharmacological and permeation properties.J. Neurosci.200020171178Available from: http://www.jneurosci.org/content/20/1/171 abstract
    [Google Scholar]
  74. PengK. ChenX.D. LiangS.P. The effect of Huwentoxin-I on Ca(2+) channels in differentiated NG108-15 cells, a patch-clamp study.Toxicon200139449149810.1016/S0041‑0101(00)00150‑1 11024489
     [Google Scholar]
  75. WangM. GuanX. LiangS. The cross channel activities of spider neurotoxin huwentoxin-I on rat dorsal root ganglion neurons.Biochem. Biophys. Res. Commun.200735757958310.1016/j.bbrc.2007.02.168
     [Google Scholar]
  76. CherkiR.S. KolbE. LangutY. TsveyerL. BajayoN. MeirA. Two tarantula venom peptides as potent and differential Na(V) channels blockers.Toxicon Pergamon201477586710.1016/j.toxicon.2013.10.029 24211312
     [Google Scholar]
  77. CardosoF.C. Multi-targeting sodium and calcium channels using venom peptides for the treatment of complex ion channels-related diseases.Biochem. Pharmacol.202018111410710.1016/j.bcp.2020.114107 32579958
     [Google Scholar]
  78. SouzaAH FerreiraJ CordeiroM do N Analgesic effect in rodents of native and recombinant Phα1β toxin, a high-voltage-activated calcium channel blocker isolated from armed spider venom.Pain2008140115126
     [Google Scholar]
  79. DoupnikC.A. Venom-derived peptides inhibiting Kir channels: Past, present, and future.Neuropharmacology201712716117210.1016/j.neuropharm.2017.07.011 28716449
     [Google Scholar]
  80. YiH. CaoZ. YinS. DaiC. WuY. LiW. Interaction simulation of hERG K+ channel with its specific BeKm-1 Peptide:  Insights into the selectivity of molecular recognition.J. Proteome Res.2007661162010.1021/pr060368g
     [Google Scholar]
  81. SuchynaT.M. JohnsonJ.H. HamerK. Identification of a peptide toxin from Grammostola spatulata spider venom that blocks cation-selective stretch-activated channels.J. Gen. Physiol.2000115558359810.1085/jgp.115.5.583 10779316
     [Google Scholar]
  82. FilippovichI. SorokinaN. MasciP.P. A family of textilinin genes, two of which encode proteins with antihaemorrhagic properties.Br. J. Haematol.2002119237638410.1046/j.1365‑2141.2002.03878.x 12406072
     [Google Scholar]
  83. BodeF. SachsF. FranzM.R. Tarantula peptide inhibits atrial fibrillation.Nature20014096816353610.1038/35051165 11343101
     [Google Scholar]
  84. SharpeI.A. GehrmannJ. LoughnanM.L. Two new classes of conopeptides inhibit the α1-adrenoceptor and noradrenaline transporter.Nat. Neurosci.20014990290710.1038/nn0901‑902 11528421
     [Google Scholar]
  85. SharpeI.A. ThomasL. LoughnanM. MotinL. PalantE. CrokerD.E. Allosteric α1-adrenoreceptor antagonism by the conopeptide ρ-TIA.J. Biol. Chem.2003278344513445710.1074/jbc.M305410200
     [Google Scholar]
  86. NicolasJP LinY LambeauG GhomashchiF LazdunskiM GelbMH Localization of structural elements of bee venom phospholipase A2 involved in N-type receptor binding and neurotoxicity.J Biol Chem199727271738110.1074/jbc.272.11.7173
     [Google Scholar]
  87. Džavík V, Lavi S, Thorpe K, Yip PM, Plante S, Ing D, et al. Interventional cardiology The sPLA 2 inhibition to decrease enzyme release after percutaneous coronary intervention (SPIDERPCI) trial.Circ is201012224118Available from: http://circ.ahajournals.org
    [Google Scholar]
/content/journals/vat/10.2174/2666121702666220425130212
Loading
Venomous Peptides as Cardiac Ion Channel’s Modulators
Ven and Tox 2, e250422204018 (2022); https://doi.org/10.2174/2666121702666220425130212
/content/journals/vat/10.2174/2666121702666220425130212
/content/journals/vat/10.2174/2666121702666220425130212
Loading

Data & Media loading...


  • Article Type:     Review Article
Keyword(s): cardiac diseases; currents; ion channels; peptides; Venoms; voltage gated channels

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test